Seattle Genetics Inc(SGEN)
127.63
Change: -5.64 (▼ -4.42%)
As of Tue 12/20/2022 11:29 AM% Of Value
Growth
Value Per Share
:
:
:
882.87
-27.63
-16.2600 (as of 19/12/2022)
Fundamentals Data
| Open | 129.37 | Dividend | 141 |
| Close Price | 127.63 | DivYield | 0 % |
| High | 129.37 | Growth | -601.1 M |
| Low | 125.4 | Growth% | -27.63 |
| P/e | -53.174 | Volume | 696,515.0 |
| P/b | -0.76 | Market Capital | 23.1 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 128.47 (as of 20/12/2022) | 50 Days Moving Average Percentage | -0.044077564052646 (as of 20/12/2022 |
| Industry: Biotechnology: Biological Products (No Diagnostic Substances) |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 482.2 M | 654.7 M | 916.7 M | 2.1 B | 1.5 B |
| Cap Spending | -70.3 M | -21.2 M | -70.7 M | -82.4 M | -52.3 M |
| Operating Expenses | 623.9 M | 826.4 M | 1.0 B | 1.3 B | 1.9 B |
| Operating Cash Flow | -195.8 M | -259.9 M | -220.5 M | 596.8 M | -682.0 M |
| Free Cash Flow | -189.2 M | -224.7 M | -234.4 M | 774.1 M | -551.3 M |
| Free Cash Flow Per Share | -1.322 | -1.426 | -1.417 | 4.428 | -3.029 |
| Total liabilities | 0.0 | 0.0 | 67.6 M | 61.8 M | 56.6 M |
| Total cash | 160.9 M | 78.1 M | 274.5 M | 558.4 M | 424.8 M |
| ROE% | -0.2 | -0.168 | -0.102 | 0.263 | -0.207 |
| Outstanding Shares | 157.9 M | 160.5 M | 172.2 M | 181.1 M | 183.6 M |
| P/E | -69.016 | -53.174 | -128.817 | 48.958 | -38.499 |
| P/S | 17.965 | 18.087 | 22.294 | 13.81 | 16.493 |
| Revenue USD | 482.2 M | 654.7 M | 916.7 M | 2.1 B | 1.5 B |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|